Literature DB >> 9342454

Persistence of porcine reproductive and respiratory syndrome virus in intensive farrow-to-finish pig herds.

W B Chung1, M W Lin, W F Chang, M Hsu, P C Yang.   

Abstract

An epidemiological study of porcine reproductive and respiratory syndrome (PRRS) within pig herds was conducted in 8 intensive farrow-to-finish pig farms. Persistence of PRRS virus (PRRSV) in pig herds was demonstrated by regular postmortem examination on 2 farms for a period of 2 y. Virus isolation and serum neutralization (SN) tests were performed on the sera collected from 9 groups of pigs (10 pigs/group) of various ages on 8 pig farms. Except for 1 farm, isolation rates of PRRSV reached the highest level of 70 to 100% of pigs 6 to 8 wk of age, which coincided with the lowest levels of maternal immunity. In 1 pig herd, sows (39 in total) with SN titers of < or = 1:2, 1:4-1:8, and > or = 1:16 were designated as groups 1, 2, and 3, respectively. Sera were obtained from their progeny (3 pigs randomly selected from each litter) at various ages from 0 to 22 weeks. A positive correlation (r = 0.377, P < 0.001) between the SN titers of sows and those of their progeny (1-week-old piglets) was observed. Pigs at the age of 6 wk, only 7.9% of group 1 pigs compared to 72.4% of group 3 pigs were seropositive. A significant difference (P < 0.01) in the percentage of pigs with PRRSV viremia among the 3 groups was observed, with the lowest level found in group 3 pigs. The isolation rates of PRRSV from serum reached the maximum at the age of 9 wk for all 3 groups. The results indicated that passively acquired serum antibodies conferred a protective effect for piglets; however, loss of passive immunity at various ages of pigs produced susceptible pigs that resulted in PRRSV persistence in the pig herds. Pigs 6 to 9 weeks old were the major reservoir for PRRSV in farrow-to-finish pig herds.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342454      PMCID: PMC1189424     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  18 in total

1.  Serologic evidence incriminating a recently isolated virus (ATCC VR-2332) as the cause of swine infertility and respiratory syndrome (SIRS).

Authors:  R B Morrison; J E Collins; L Harris; W T Christianson; D A Benfield; D W Chladek; D E Gorcyca; H S Joo
Journal:  J Vet Diagn Invest       Date:  1992-04       Impact factor: 1.279

2.  Experimental reproduction of porcine epidemic abortion and respiratory syndrome (mystery swine disease) by infection with Lelystad virus: Koch's postulates fulfilled.

Authors:  C Terpstra; G Wensvoort; J M Pol
Journal:  Vet Q       Date:  1991-07       Impact factor: 3.320

3.  Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs.

Authors:  J E Collins; D A Benfield; W T Christianson; L Harris; J C Hennings; D P Shaw; S M Goyal; S McCullough; R B Morrison; H S Joo
Journal:  J Vet Diagn Invest       Date:  1992-04       Impact factor: 1.279

Review 4.  Lelystad virus and the porcine epidemic abortion and respiratory syndrome.

Authors:  G Wensvoort
Journal:  Vet Res       Date:  1993       Impact factor: 3.683

5.  Enhanced replication of porcine reproductive and respiratory syndrome (PRRS) virus in a homogeneous subpopulation of MA-104 cell line.

Authors:  H S Kim; J Kwang; I J Yoon; H S Joo; M L Frey
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

6.  Pathogenesis of porcine reproductive and respiratory syndrome virus infection in mid-gestation sows and fetuses.

Authors:  W T Christianson; C S Choi; J E Collins; T W Molitor; R B Morrison; H S Joo
Journal:  Can J Vet Res       Date:  1993-10       Impact factor: 1.310

7.  Endemic porcine reproductive and respiratory syndrome virus infection of nursery pigs in two swine herds without current reproductive failure.

Authors:  G W Stevenson; W G Van Alstine; C L Kanitz; K K Keffaber
Journal:  J Vet Diagn Invest       Date:  1993-07       Impact factor: 1.279

8.  Mystery swine disease in The Netherlands: the isolation of Lelystad virus.

Authors:  G Wensvoort; C Terpstra; J M Pol; E A ter Laak; M Bloemraad; E P de Kluyver; C Kragten; L van Buiten; A den Besten; F Wagenaar
Journal:  Vet Q       Date:  1991-07       Impact factor: 3.320

9.  Molecular characterization of porcine reproductive and respiratory syndrome virus, a member of the arterivirus group.

Authors:  K K Conzelmann; N Visser; P Van Woensel; H J Thiel
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

10.  Lelystad virus, the causative agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV.

Authors:  J J Meulenberg; M M Hulst; E J de Meijer; P L Moonen; A den Besten; E P de Kluyver; G Wensvoort; R J Moormann
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

View more
  13 in total

1.  Global trends in antimicrobial use in food animals.

Authors:  Thomas P Van Boeckel; Charles Brower; Marius Gilbert; Bryan T Grenfell; Simon A Levin; Timothy P Robinson; Aude Teillant; Ramanan Laxminarayan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-19       Impact factor: 11.205

2.  Comparison of molecular and biological characteristics of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (ingelvac PRRS MLV), the parent strain of the vaccine (ATCC VR2332), ATCC VR2385, and two recent field isolates of PRRSV.

Authors:  T Opriessnig; P G Halbur; K-J Yoon; R M Pogranichniy; K M Harmon; R Evans; K F Key; F J Pallares; P Thomas; X J Meng
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Reproductive parameters following a PRRS outbreak where a whole-herd PRRS MLV vaccination strategy was instituted post-outbreak.

Authors:  Em-on Olanratmanee; Suparlark Nuntawan Na Ayudhya; Roongroje Thanawongnuwech; Annop Kunavongkrit; Padet Tummaruk
Journal:  Trop Anim Health Prod       Date:  2012-12-02       Impact factor: 1.559

4.  Reproductive performance of sows with and without PRRS modified live virus vaccination in PRRS-virus-seropositive herds.

Authors:  Em-On Olanratmanee; Roongroje Thanawongnuwech; Annop Kunavongkrit; Padet Tummaruk
Journal:  Trop Anim Health Prod       Date:  2014-05-10       Impact factor: 1.559

5.  Evaluation of the efficacy of an attenuated live vaccine against highly pathogenic porcine reproductive and respiratory syndrome virus in young pigs.

Authors:  Xue Leng; Zhenguang Li; Mingqi Xia; Yanliang He; Hua Wu
Journal:  Clin Vaccine Immunol       Date:  2012-06-13

6.  BPEX Pig Health Scheme: a useful monitoring system for respiratory disease control in pig farms?

Authors:  Hannah R Holt; Pablo Alarcon; Martina Velasova; Dirk U Pfeiffer; Barbara Wieland
Journal:  BMC Vet Res       Date:  2011-12-30       Impact factor: 2.741

7.  Initial vaccination and revaccination with Type I PRRS 94881 MLV reduces viral load and infection with porcine reproductive and respiratory syndrome virus.

Authors:  Jeremy Kroll; Michael Piontkowski; Christian Kraft; Teresa Coll; Oliver Gomez-Duran
Journal:  Porcine Health Manag       Date:  2018-08-20

8.  Interaction of Type 1 Porcine Reproductive and Respiratory Syndrome Virus With In Vitro Derived Conventional Dendritic Cells.

Authors:  Yanli Li; Enric Mateu
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

9.  Positive effects of porcine IL-2 and IL-4 on virus-specific immune responses induced by the porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 DNA vaccine in swine.

Authors:  Deyuan Tang; Jian Liu; Chunyan Li; Hua Zhang; Ping Ma; Xianfeng Luo; Zhiyong Zeng; Nining Hong; Xia Liu; Bin Wang; Feng Wang; Zhenlei Gan; Fei Hao
Journal:  J Vet Sci       Date:  2013-10-18       Impact factor: 1.672

10.  Vaccination of 1-day-old pigs with a porcine reproductive and respiratory syndrome virus (PRRSV) modified live attenuated virus vaccine is able to overcome maternal immunity.

Authors:  Monica Balasch; Maria Fort; Lucas P Taylor; Jay G Calvert
Journal:  Porcine Health Manag       Date:  2018-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.